Nuventra Pharma Sciences is now Allucent. Learn more here.

Take a deeper dive

News & Events

Nuventra’s Brandon Burch to Speak at DIA 2020 Virtual Annual Meeting

Nuventra’s Associate Director of Scientific Writing and Regulatory Affairs, Brandon Burch, Ph.D., will present during the session titled, Storyboarding for Key Message Alignment in Marketing Applicationsat this years’ DIA Annual Meeting that has now gone virtual. The session will become available on-demand on Thursday, June 18th at 5:00pm EDT.

Dr. Burch’s presentation is titled, “Beginning with the End in Mind: Positioning Clinical Pharmacology Messaging from Phase 1 to NDA.” This talk will describe how to use the Target Product Profile (TPP) and Clinical Pharmacology Plan to define and communicate program goals, map out an efficient strategy for achieving these goals, and ensure effective messaging throughout development. The talk will also provide an introduction to the other presentations in the session, including discussions about the MIRS (Messages, Issues, Responses, Support) Tool and Storyboarding. The presentations will be followed by a short Question and Answer session where the speakers will address key questions about these tools and how they can be used effectively.

Dr. Burch has been with Nuventra since May 2014 with a primary focus on regulatory affairs, medical and scientific writing, and project management, and currently heads Nuventra’s Regulatory Affairs and Medical Writing department. He has helped prepare and coordinate INDs, NDAs, and BLAs across a variety of drug classes and therapeutic areas. His experience includes regulatory strategy and submissions, program assessments, and authoring regulatory, scientific, and technical documents. Prior to joining Nuventra, he was a postdoctoral research fellow in the Department of Medicine at the University of North Carolina at Chapel Hill. He earned a Ph.D. in genetics and molecular biology from UNC and an M.S. in biology from East Carolina University.